Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2025-12-25 @ 2:03 AM
NCT ID:
NCT01012960
Eligibility Criteria:
Inclusion Criteria:
* 18 -40 year old healthy volunteers from both sexes.
* have signed and dated Informed Consent.
* willing and able to comply with the protocol for the duration of the trial.
Exclusion Criteria:
* anamnesis of pharyngoesophageal dysfunction.
* known or history of cardiac, pulmonary or neurological disease.
* ongoing medication.
* allergies to or history of reaction to methylnaltrexone, remifentanil or fentanyl analogues.
* pregnancy or breast feeding.
* participation in another clinical medicinal trial during the last 30 days or where follow-up is not completed.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
40 Years
Study:
NCT01012960
Study Brief:
Protocol Section:
NCT01012960